| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCULATIONAHA.109.898312 |
| P698 | PubMed publication ID | 20176987 |
| P50 | author | Qizhou Lian | Q35705102 |
| Chuen Neng Lee | Q39393110 | ||
| P2093 | author name string | Yang Zhang | |
| Hung-Fat Tse | |||
| Chung-Wah Siu | |||
| Yuelin Zhang | |||
| Ka-Wing Au | |||
| Jinqiu Zhang | |||
| Wing-Hong Lai | |||
| Francis Fu-Yuen Lam | |||
| Sarang Kang | |||
| Xingang Wu | |||
| Hua Kun Zhang | |||
| Jian Chuan Xia | |||
| Yen Yen Chow | |||
| P2860 | cites work | Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins | Q24653753 |
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Human induced pluripotent stem cells free of vector and transgene sequences | Q29547624 | ||
| Pluripotency of mesenchymal stem cells derived from adult marrow | Q29617959 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | limb ischemia | Q18553514 |
| Human Induced Pluripotent Stem Cells | Q88981775 | ||
| P304 | page(s) | 1113-1123 | |
| P577 | publication date | 2010-02-22 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice | |
| P478 | volume | 121 |
| Q30498095 | A mesoderm-derived precursor for mesenchymal stem and endothelial cells |
| Q37211530 | A self-setting iPSMSC-alginate-calcium phosphate paste for bone tissue engineering |
| Q39380660 | A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds. |
| Q26822437 | Advancements in stem cells treatment of skeletal muscle wasting |
| Q91755491 | Amelioration of Endoplasmic Reticulum Stress by Mesenchymal Stem Cells via Hepatocyte Growth Factor/c-Met Signaling in Obesity-Associated Kidney Injury |
| Q87128563 | An expanded population of CD34+ cells from frozen banked umbilical cord blood demonstrate tissue repair mechanisms of mesenchymal stromal cells and circulating angiogenic cells in an ischemic hind limb model |
| Q90594848 | An in Vitro and in Vivo Study of the Effect of Dexamethasone on Immunoinhibitory Function of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells |
| Q90236280 | An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy |
| Q38201302 | An update of human mesenchymal stem cell biology and their clinical uses. |
| Q57767309 | Angiogenic potential of BM MSCs derived from patients with critical leg ischemia |
| Q36673714 | Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells |
| Q36336661 | Bone tissue engineering via human induced pluripotent, umbilical cord and bone marrow mesenchymal stem cells in rat cranium. |
| Q50897287 | CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa. |
| Q90149810 | Cell Therapy: Effect of Locally Injected Mesenchymal Stromal Cells Derived from Bone Marrow or Adipose Tissue on Bone Regeneration of Rat Calvarial Defects |
| Q35570010 | Cell sources for bone regeneration: the good, the bad, and the ugly (but promising). |
| Q34513293 | Cells derived from murine induced pluripotent stem cells (iPSC) by treatment with members of TGF-beta family give rise to osteoblasts differentiation and form bone in vivo. |
| Q36105161 | Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia |
| Q64093314 | Characterization and Therapeutic Application of Mesenchymal Stem Cells with Neuromesodermal Origin from Human Pluripotent Stem Cells |
| Q42087648 | Characterization of Mesenchymal Stem Cell-Like Cells Derived From Human iPSCs via Neural Crest Development and Their Application for Osteochondral Repair. |
| Q35858874 | Characterization of Proliferating Neural Progenitors after Spinal Cord Injury in Adult Zebrafish |
| Q40244927 | Characterization of the Cellular Output of a Point-of-Care Device and the Implications for Addressing Critical Limb Ischemia |
| Q34957259 | Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma |
| Q38002947 | Clinical utility of stem cells for periodontal regeneration. |
| Q50675460 | Co-Seeding Human Endothelial Cells with Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells on Calcium Phosphate Scaffold Enhances Osteogenesis and Vascularization in Rats |
| Q37200221 | Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. |
| Q37838864 | Concise review: induced pluripotent stem cells and lineage reprogramming: prospects for bone regeneration |
| Q38267714 | Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions |
| Q93115886 | Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells |
| Q57814615 | Connexin 43-Mediated Mitochondrial Transfer of iPSC-MSCs Alleviates Asthma Inflammation |
| Q35000509 | Critical-size calvarial bone defects healing in a mouse model with silk scaffolds and SATB2-modified iPSCs |
| Q58702140 | Current Strategies to Generate Human Mesenchymal Stem Cells In Vitro |
| Q92854054 | Current Trends and Future Perspective of Mesenchymal Stem Cells and Exosomes in Corneal Diseases |
| Q38132747 | Dedifferentiated adipocyte-derived progeny cells (DFAT cells): Potential stem cells of adipose tissue |
| Q36547230 | Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates. |
| Q36911067 | Dimethyloxaloylglycine Promotes the Angiogenic Activity of Mesenchymal Stem Cells Derived from iPSCs via Activation of the PI3K/Akt Pathway for Bone Regeneration |
| Q48708784 | Directed Differentiation of Human-Induced Pluripotent Stem Cells to Mesenchymal Stem Cells. |
| Q64277481 | Donation of mitochondria by iPSC-derived mesenchymal stem cells protects retinal ganglion cells against mitochondrial complex I defect-induced degeneration |
| Q37413897 | Effect of bovine pericardial extracellular matrix scaffold niche on seeded human mesenchymal stem cell function |
| Q37676765 | Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells |
| Q31018198 | Effects on duration of post-operative ischemia and patterns of blood flow recovery in different conditions of mouse hind limb ischemia |
| Q41819566 | Efficient differentiation of human pluripotent stem cells into mesenchymal stem cells by modulating intracellular signaling pathways in a feeder/serum-free system |
| Q52681668 | Embryonic Stem Cell-Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic-Ischemic Mouse Brain. |
| Q33651561 | Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application |
| Q92715308 | Emerging opportunities for induced pluripotent stem cells in orthopaedics |
| Q33991356 | Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease |
| Q57300360 | Endowing iPSC-Derived MSCs with Angiogenic and Keratinogenic Differentiation Potential: A Promising Cell Source for Skin Tissue Engineering |
| Q50074722 | Engineering Stem and Stromal Cell Therapies for Musculoskeletal Tissue Repair. |
| Q27026414 | Engineering mesenchymal stem cells for regenerative medicine and drug delivery |
| Q38091202 | Engineering the human pluripotent stem cell microenvironment to direct cell fate |
| Q40253067 | Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci. |
| Q33840774 | Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells |
| Q37675908 | Exosomes Secreted from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Prevent Osteonecrosis of the Femoral Head by Promoting Angiogenesis |
| Q57476066 | Exosomes Secreted from Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Accelerate Skin Cell Proliferation |
| Q35212390 | Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. |
| Q35944791 | Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice |
| Q37267659 | Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway |
| Q56334462 | Exposure of Endothelium to Biomimetic Flow Waveforms Yields Identification of miR-199a-5p as a Potent Regulator of Arteriogenesis |
| Q27339281 | Fibroblasts derived from human pluripotent stem cells activate angiogenic responses in vitro and in vivo |
| Q33862395 | Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. |
| Q54305048 | Functional ginger extracts from supercritical fluid carbon dioxide extraction via in vitro and in vivo assays: antioxidation, antimicroorganism, and mice xenografts models. |
| Q35764559 | Gene therapy: implications for craniofacial regeneration |
| Q42029999 | Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells |
| Q33588019 | Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines. |
| Q50270780 | Generation of human induced pluripotent stem cells from osteoarthritis patient-derived synovial cells |
| Q92573477 | Generation of mesenchymal stem-like cells for producing extracellular vesicles |
| Q48207335 | Genetic enhancement in cultured human adult stem cells conferred by a single nucleotide recoding |
| Q47114724 | Glutathione Peroxidase 3 Delivered by hiPSC-MSCs Ameliorated Hepatic IR Injury via Inhibition of Hepatic Senescence |
| Q42659118 | Growth/differentiation factor-5 promotes in vitro/vivo periodontal specific differentiation of induced pluripotent stem cell-derived mesenchymal stem cells |
| Q35814062 | Human Gingival Integration-Free iPSCs; a Source for MSC-Like Cells |
| Q37350696 | Human Induced Pluripotent Stem Cells Differentiate Into Functional Mesenchymal Stem Cells and Repair Bone Defects |
| Q35679622 | Human Ocular Epithelial Cells Endogenously Expressing SOX2 and OCT4 Yield High Efficiency of Pluripotency Reprogramming. |
| Q37911584 | Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation |
| Q38777407 | Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases. |
| Q64083257 | Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature |
| Q91015254 | Human iPSC-derived iMSCs improve bone regeneration in mini-pigs |
| Q52673819 | Human iPSC-derived mesenchymal stem cells encapsulated in PEGDA hydrogels mature into valve interstitial-like cells. |
| Q47139383 | Human induced pluripotent stem cell-derived mesenchymal stem cells prevent adriamycin nephropathy in mice |
| Q90317210 | Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-α-stimulated gene-6 in inflammatory bowel disease models |
| Q48564423 | Human induced pluripotent stem cell‑derived mesenchymal stem cells alleviate atherosclerosis by modulating inflammatory responses |
| Q37536743 | Human pluripotent stem cell (PSC)-derived mesenchymal stem cells (MSCs) show potent neurogenic capacity which is enhanced with cytoskeletal rearrangement |
| Q36546924 | Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice |
| Q33788845 | Human stem cells for craniomaxillofacial reconstruction. |
| Q52902814 | Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells as an Individual-Specific and Renewable Source of Adult Stem Cells. |
| Q55280335 | IPSC‑MSC inhibition assessment in Raw 264.7 cells following oxygen and glucose deprivation reveals a distinct function for cardiopulmonary resuscitation. |
| Q34130859 | Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension. |
| Q38868645 | Immunomodulatory Properties of Induced Pluripotent Stem Cell-Derived Mesenchymal Cells. |
| Q49289725 | Immunosuppressive Mesenchymal Stromal Cells Derived from Human-Induced Pluripotent Stem Cells Induce Human Regulatory T Cells In Vitro and In Vivo |
| Q35087368 | Improvement of In Vitro Osteogenic Potential through Differentiation of Induced Pluripotent Stem Cells from Human Exfoliated Dental Tissue towards Mesenchymal-Like Stem Cells |
| Q46133022 | In Vivo Rescue of the Hematopoietic Niche By Pluripotent Stem Cell Complementation of Defective Osteoblast Compartments. |
| Q33846452 | In vivo repair of full-thickness cartilage defect with human iPSC-derived mesenchymal progenitor cells in a rabbit model |
| Q33848594 | Increased activity of TNAP compensates for reduced adenosine production and promotes ectopic calcification in the genetic disease ACDC. |
| Q26738393 | Induced Pluripotent Stem (iPS) Cells in Dentistry: A Review |
| Q26777488 | Induced Pluripotent Stem Cells and Periodontal Regeneration |
| Q92001240 | Induced Pluripotent Stem Cells in Dental and Nondental Tissue Regeneration: A Review of an Unexploited Potential |
| Q38626650 | Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells Attenuate Cigarette Smoke-Induced Cardiac Remodeling and Dysfunction. |
| Q38569134 | Induced Pluripotent Stem Cells: A New Frontier for Stem Cells in Dentistry. |
| Q37812563 | Induced pluripotent cancer cells: progress and application |
| Q33877155 | Induced pluripotent stem cell: A headway in reprogramming with promising approach in regenerative biology |
| Q39025414 | Induced pluripotent stem cells as a new getaway for bone tissue engineering: A systematic review. |
| Q36405220 | Inducing iPSCs to escape the dish. |
| Q45851611 | Induction of functional mesenchymal stem cells from rabbit embryonic stem cells by exposure to severe hypoxic conditions. |
| Q36285923 | Induction of hair follicle dermal papilla cell properties in human induced pluripotent stem cell-derived multipotent LNGFR(+)THY-1(+) mesenchymal cells |
| Q46238021 | Intrinsic Immunity Shapes Viral Resistance of Stem Cells |
| Q92994147 | JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia |
| Q42158332 | Kindlin-2 Modulates the Survival, Differentiation, and Migration of Induced Pluripotent Cell-Derived Mesenchymal Stromal Cells |
| Q58114743 | Matrix stiffness modulates the differentiation of neural crest stem cells in vivo |
| Q88884604 | Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges |
| Q52595779 | Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose-Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model. |
| Q35864084 | Mesenchymal Stem Cells Obtained from Synovial Fluid Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells on a Matrigel Coating Exhibited Enhanced Proliferation and Differentiation Potential |
| Q28354224 | Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy |
| Q64881336 | Mesenchymal Stem Cells-Potential Applications in Kidney Diseases. |
| Q57776815 | Mesenchymal Stem Cells: An Optimistic Cell Source in Tissue Engineering for Bone Regeneration |
| Q98158954 | Mesenchymal Stem/Stromal Cell-Mediated Mitochondrial Transfer and the Therapeutic Potential in Treatment of Neurological Diseases |
| Q35818125 | Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction |
| Q26785623 | Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives |
| Q26770191 | Mesenchymal stem cells and immunomodulation: current status and future prospects |
| Q36930468 | Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy |
| Q36563846 | Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis |
| Q38843031 | Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity |
| Q89519701 | Mesenchymal stem cells derived from iPSCs expressing interleukin-24 inhibit the growth of melanoma in the tumor-bearing mouse model |
| Q34359730 | Mesenchymal stem cells from iPS cells facilitate periodontal regeneration |
| Q58695273 | Mesenchymal stem cells overexpressing IL-35: a novel immunosuppressive strategy and therapeutic target for inducing transplant tolerance |
| Q28085040 | Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds |
| Q35136732 | Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization |
| Q48156971 | Metformin induces osteoblastic differentiation of human induced pluripotent stem cell-derived mesenchymal stem cells. |
| Q64329103 | MicroRNA-21 Mediates the Protective Effects of Mesenchymal Stem Cells Derived from iPSCs to Human Bronchial Epithelial Cell Injury Under Hypoxia |
| Q30525670 | Microfluidic single-cell analysis shows that porcine induced pluripotent stem cell-derived endothelial cells improve myocardial function by paracrine activation |
| Q39003484 | Mitochondrial transfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage |
| Q30836161 | Mitochondrial transfer of mesenchymal stem cells effectively protects corneal epithelial cells from mitochondrial damage |
| Q48806747 | Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells |
| Q36588683 | Modeling the blood-brain barrier using stem cell sources |
| Q36908997 | Modulating the vascular response to limb ischemia: angiogenic and cell therapies. |
| Q64912724 | Multiplicity of Mesenchymal Stromal Cells: Finding the Right Route to Therapy. |
| Q38183144 | Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons? |
| Q39014215 | Murine Rankl-/- Mesenchymal Stromal Cells Display an Osteogenic Differentiation Defect Improved by a RANKL-Expressing Lentiviral Vector |
| Q38201281 | On the road to bioartificial organs |
| Q27015774 | Optimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cells |
| Q35876527 | Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo |
| Q38168864 | Osteogenically differentiated mesenchymal stem cells and ceramics for bone tissue engineering |
| Q37664120 | Overexpression of myocardin induces partial transdifferentiation of human-induced pluripotent stem cell-derived mesenchymal stem cells into cardiomyocytes |
| Q36010393 | PDGFRβ expression and function in fibroblasts derived from pluripotent cells is linked to DNA demethylation |
| Q38107063 | Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. |
| Q33760206 | Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model |
| Q38097512 | Perspective and challenges of mesenchymal stem cells for cardiovascular regeneration. |
| Q36029693 | Pluripotent Stem Cells and Skeletal Regeneration--Promise and Potential |
| Q35702033 | Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy |
| Q64055065 | Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure |
| Q55091774 | Potential of iPSC-Derived Mesenchymal Stromal Cells for Treating Periodontal Disease. |
| Q33998015 | Preconditioning stem cells for in vivo delivery. |
| Q93366161 | Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury |
| Q64249676 | Production of Mesenchymal Stem Cells Through Stem Cell Reprogramming |
| Q27015655 | Promises of stem cell therapy for retinal degenerative diseases |
| Q89763828 | Prospective isolation of chondroprogenitors from human iPSCs based on cell surface markers identified using a CRISPR-Cas9-generated reporter |
| Q26776053 | Prospects and Challenges of Induced Pluripotent Stem Cells in Equine Health |
| Q35234024 | Radiation response of mesenchymal stem cells derived from bone marrow and human pluripotent stem cells |
| Q36810424 | Rapid and efficient reprogramming of human fetal and adult blood CD34+ cells into mesenchymal stem cells with a single factor. |
| Q26740433 | Recent Progress in Stem Cell Therapy for Diabetic Nephropathy |
| Q38327021 | Regeneration of degenerated urinary sphincter muscles: improved stem cell-based therapies and novel imaging technologies |
| Q43124732 | Regenerative medicine: Cartilage transplants hold promise for challenging bone defects |
| Q50251918 | Regulation of cell proliferation of human induced pluripotent stem cell-derived mesenchymal stem cells via ether-à-go-go 1 (hEAG1) potassium channel |
| Q26800082 | Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand? |
| Q37353596 | Reprogramming of mesenchymal stem cells derived from iPSCs seeded on biofunctionalized calcium phosphate scaffold for bone engineering |
| Q47325140 | Restoration of SMN expression in mesenchymal stem cells derived from gene-targeted patient-specific iPSCs |
| Q54315274 | Reversal of endothelial progenitor cell dysfunction in patients with type 2 diabetes using a conditioned medium of human embryonic stem cell-derived endothelial cells. |
| Q52716131 | Robust Revascularization in Models of Limb Ischemia Using a Clinically Translatable Human Stem Cell-Derived Endothelial Cell Product. |
| Q49677594 | Safety and immune regulatory properties of canine induced pluripotent stem cell-derived mesenchymal stem cells. |
| Q38216498 | Self-renewal and cell lineage differentiation strategies in human embryonic stem cells and induced pluripotent stem cells. |
| Q26742060 | Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy |
| Q96126108 | Small extracellular vesicles derived from human MSCs prevent allergic airway inflammation via immunomodulation on pulmonary macrophages |
| Q90013839 | Small extracellular vesicles derived from human mesenchymal stromal cells prevent group 2 innate lymphoid cell-dominant allergic airway inflammation through delivery of miR-146a-5p |
| Q39078705 | Small-diameter vascular graft engineered using human embryonic stem cell-derived mesenchymal cells |
| Q26862581 | Smooth muscle and other cell sources for human blood vessel engineering |
| Q30430026 | Spatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the endogenous response and therapeutic implications |
| Q38275024 | Stem Cell Transplantation for Hematological Malignancies: Prospects for Personalized Medicine and Co-therapy with Mesenchymal Stem Cells |
| Q42862294 | Stem Cells and Healing: Impact on Inflammation |
| Q38559646 | Stem Cells on Biomaterials for Synthetic Grafts to Promote Vascular Healing |
| Q36303725 | Stem and progenitor cells: advancing bone tissue engineering |
| Q38279899 | Stem cell therapies for treating osteoarthritis: prescient or premature? |
| Q26852277 | Strategies for Oral Mucosal Repair by Engineering 3D Tissues with Pluripotent Stem Cells |
| Q38040207 | Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury. |
| Q92394719 | Targeting Purinergic Signaling and Cell Therapy in Cardiovascular and Neurodegenerative Diseases |
| Q37702584 | Telomerase protects Werner syndrome lineage-specific stem cells from premature aging. |
| Q26860309 | The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges |
| Q37348530 | The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential |
| Q41718625 | The combination of stem cells and tissue engineering: an advanced strategy for blood vessels regeneration and vascular disease treatment |
| Q38177679 | The current state of stem cell therapy for peripheral artery disease |
| Q37563956 | The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment |
| Q64106014 | The potential and limitations of induced pluripotent stem cells to achieve wound healing |
| Q37959064 | The proarrhythmic risk of cell therapy for cardiovascular diseases |
| Q33771698 | The stem cell secretome and its role in brain repair |
| Q28066984 | Therapeutic Potential of Human Mesenchymal Stem Cells for Treating Ischemic Limb Diseases |
| Q33825829 | Therapeutic effect of TSG-6 engineered iPSC-derived MSCs on experimental periodontitis in rats: a pilot study |
| Q36633005 | Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia. |
| Q44414964 | Therapeutic potential of human induced pluripotent stem cell-derived mesenchymal stem cells in mice with lethal fulminant hepatic failure |
| Q90396259 | Transfer of mitochondria from mesenchymal stem cells derived from induced pluripotent stem cells attenuates hypoxia-ischemia-induced mitochondrial dysfunction in PC12 cells |
| Q36097710 | Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Critical Limb Ischemia in Diabetic Nude Rats |
| Q42819955 | Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. |
| Q90533114 | Transplantation of induced pluripotent stem cell-derived mesenchymal stem cells improved erectile dysfunction induced by cavernous nerve injury |
| Q30751275 | Transplantation of mesenchymal cells improves peripheral limb ischemia in diabetic rats. |
| Q57042168 | Transplanted human pluripotent stem cell-derived mesenchymal stem cells support liver regeneration in Gunn rats |
| Q39240834 | Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials |
| Q36519821 | Type 2 diabetes restricts multipotency of mesenchymal stem cells and impairs their capacity to augment postischemic neovascularization in db/db mice |
| Q39167308 | Umbilical cord blood-derived CD34⁺ cells improve outcomes of traumatic brain injury in rats by stimulating angiogenesis and neurogenesis |
| Q28083072 | Vascular diseases await translation of blood vessels engineered from stem cells |
| Q38152909 | Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease? |
| Q93165374 | Vitamin C Treatment Rescues Prelamin A-Induced Premature Senescence of Subchondral Bone Mesenchymal Stem Cells |
| Q88739377 | [Effect of bone morphogenetic protein-4 overexpression on the biological activity of mouse induced pluripotent stem cells] |
| Q41947844 | hiPS-MSCs differentiation towards fibroblasts on a 3D ECM mimicking scaffold |
| Q26751506 | hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine |
| Q38733804 | iPS cell technologies and their prospect for bone regeneration and disease modeling: A mini review |
| Q35866047 | iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation |
| Q37338277 | iPSC-MSCs with High Intrinsic MIRO1 and Sensitivity to TNF-α Yield Efficacious Mitochondrial Transfer to Rescue Anthracycline-Induced Cardiomyopathy. |
| Q39662367 | iPSC-derived fibroblasts demonstrate augmented production and assembly of extracellular matrix proteins |
| Q37604374 | iPSC-derived mesenchymal stem cells exert SCF-dependent recovery of cigarette smoke-induced apoptosis/proliferation imbalance in airway cells. |
| Q38711725 | microRNA-21 Mediates the Protective Effects of Mesenchymal Stem Cells Derived from iPSCs to Human Bronchial Epithelial Cell Injury Under Hypoxia |
Search more.